DEVELOPMENT OF INTRAVENOUS DRUG GANAXOLONE
$33,656,933
| Recipient | IMMEDICA PHARMA US INC. UEI MS6UM2NBDW91 |
|---|---|
| Award ID | 75A50120C00159 |
| Award amount | $33,656,933 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Start date | Sep 8, 2020 |
| End date | Dec 31, 2025 |
| Place of performance | WAYNE, PA |
| Record updated | Jun 12, 2024 |
View the official award record
More awards won by IMMEDICA PHARMA US INC.
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $3,200,000 · Dec 1, 2023
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids